ClinConnect ClinConnect Logo
Search / Trial NCT06946381

CAMpania PugliA bRanch Iliaco

Launched by FEDERICO II UNIVERSITY · Apr 23, 2025

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Evar Bevar Aaa

ClinConnect Summary

The CAMpania PugliA bRanch Iliaco trial is a research study looking at how well a specific medical device called the E-liac Branch Device works for treating aortoiliac aneurysms, which are bulges in the blood vessels in the lower part of the abdomen. This study will track the performance of this device over time in real patients to see how effective it is in everyday healthcare settings.

To participate in this trial, patients should have an aortoiliac or aortic aneurysm that needs treatment, and they will be treated with the E-liac stent-graft system, either by itself or along with other devices. The study is open to all adults, and it's important to note that patients who do not wish to join or have been treated with different devices will not be included. Those who take part can expect regular follow-ups to monitor their health and the results of the treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • An aortoiliac or aortic aneurysm of surgical interest based on the most recent local guidelines treated with the E-liac stent-graft system, alone or in combination with other devices
  • Exclusion Criteria:
  • Patient's refusal to be enrolled in the registry
  • Patient treated with devices not including the E-liac stent-graft system

About Federico Ii University

Federico II University, located in Naples, Italy, is a prestigious academic institution with a strong emphasis on advanced research and clinical innovation. As a clinical trial sponsor, the university is committed to fostering the development of novel therapeutic interventions and enhancing patient care through rigorous scientific inquiry. With a multidisciplinary approach, Federico II University collaborates with healthcare professionals, researchers, and industry partners to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its dedication to improving health outcomes is reflected in its robust research programs and commitment to translating scientific findings into clinical practice.

Locations

Naples, , Italy

Bari, Ba, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported